Published in Lab Business Week, August 12th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Martek Biosciences Corporation.
Report 1: Martek Biosciences Corporation (NASDAQ:MATK) announced that it has withdrawn its original European ARA (arachidonic acid) patent for infant formula that was upheld with narrowed claims by the European Patent Office (EPO) in April 2005. As a result of the withdrawal, an appeal hearing scheduled for July 2007 is to be canceled and the patent will no longer be in force and effect.
Martek has taken this action because, on April 11,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.